Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study ; volume:14 ; number:1 ; day:27 ; month:3 ; year:2024 ; pages:1-12 ; date:12.2024
Annals of intensive care ; 14, Heft 1 (27.3.2024), 1-12, 12.2024
- Creator
-
Levy, Bruno
Girerd, Nicolas
Baudry, Guillaume
Duarte, Kevin
Cuau, Samuel
Bakker, Jan
Kimmoun, Antoine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13613-024-01266-6
- URN
-
urn:nbn:de:101:1-2406130851137.896236556114
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Levy, Bruno
- Girerd, Nicolas
- Baudry, Guillaume
- Duarte, Kevin
- Cuau, Samuel
- Bakker, Jan
- Kimmoun, Antoine
- SpringerLink (Online service)
Other Objects (12)
Postcardiotomy VA-ECMO for refractory cardiogenic shock
ECMO in cardiac arrest and cardiogenic shock
Should ECMO be used in cardiogenic shock?
Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
Do we need another prognostic score for cardiogenic shock patients with ECMO?
ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Correction to: ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Quo vadis ECMO?
ECMO in Poisoning
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
Angiotensin in ECMO patients with refractory shock
Pneumonectomy following penetrating trauma with ECMO as postoperative support: case report – (Lung trauma and ECMO)
Postcardiotomy VA-ECMO for refractory cardiogenic shock
ECMO in cardiac arrest and cardiogenic shock
Should ECMO be used in cardiogenic shock?
Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
Do we need another prognostic score for cardiogenic shock patients with ECMO?
ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Correction to: ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Quo vadis ECMO?
ECMO in Poisoning
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
Angiotensin in ECMO patients with refractory shock
Pneumonectomy following penetrating trauma with ECMO as postoperative support: case report – (Lung trauma and ECMO)
Postcardiotomy VA-ECMO for refractory cardiogenic shock
ECMO in cardiac arrest and cardiogenic shock
Should ECMO be used in cardiogenic shock?
Surgical outcomes in cardiogenic shock patients with preoperative extracorporeal membrane oxygenation (ECMO)
Do we need another prognostic score for cardiogenic shock patients with ECMO?
ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Correction to: ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period
Quo vadis ECMO?
ECMO in Poisoning
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
Angiotensin in ECMO patients with refractory shock